Business news from Equality Health, Yosi Health, PreciseMDX, Neura Health, Lightbeam Health Solutions, Curebase, Motient, Biofourmis, Implicity, CareCloud, MobileSmith Health, and more.
Read More
The thought leaders in our community are good about sharing their thoughts on the issues of today. Here are the top read and shared guest posts of March that we think deserve sharing again.
By Jessica Scruton BSN RN CCM-R – According to the CDC, there are over 130 million Emergency Department visits each year, with over 16.2 million resulting in admission to the hospital. CMS says that one of the goals of primary care should be to reduce unnecessary emergency department visits.
Attending HIMSS22? Now with in-person and digital registration options, attendees can choose their path to the conference—allowing for a personalized experience with even more value. Here are some sessions we thought would be interesting. See you in Orlando!
By Shelley Davis MSN RNC CCM – The healthcare industry is undergoing an evolution towards retail service, driven in large part by the growing influence of consumers in the marketplace. Younger patients have largely moved away from the traditional care delivery model that has sustained healthcare for so long.
Heading to the HIMSS conference in Orlando this March? Add these booths to your trip to the exhibit hall. Say hi and tell them HealthIT Answers and Healthcare NOW Radio sent you. See you in Orlando!
A star-studded line-up of speakers have signed on to contribute from all over the health care industry. Here are some we would like to highlight. Check the conference site agenda for updated locations for these sessions and events. See you in Miami!
Business news from GenieMD, Clear Arch Health, Lightbeam Health Solutions, symplr, DispatchHealth, Huron, Kiira Health, GE Healthcare, Babylon, Core xRM, Phreesia, Insignia Health, Availity, Motient, and more.
Will we still be discussing the pandemic impact at the end of 2022? Our industry experts and thought leaders have shared their predictions for 2022 with us over the last few weeks. Here are some final thoughts.